(FXI) iShares China Large-Cap - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US4642871846 • China Region
FXI: Chinese, Stocks, Companies, Hong Kong
The iShares China Large-Cap ETF (FXI) is a U.S.-domiciled fund designed to track the performance of the largest and most liquid Chinese companies listed on the Stock Exchange of Hong Kong. These companies are part of the FTSE China 50 Index, which focuses on firms that are accessible to international investors. The fund invests at least 80% of its assets in the underlying index components or in securities with equivalent economic characteristics, ensuring tight tracking of the index.
FXI provides exposure to some of Chinas most prominent companies, primarily in sectors like technology, finance, and energy. As a non-diversified fund, it can have higher concentrations in its top holdings, which may amplify both returns and risks. The fund is listed on the NYSE ARCA under the ticker FXI, with a market capitalization of over $7.7 billion, making it one of the larger ETFs focused on Chinese equities. It’s important to note that FXI does not invest directly in China’s onshore market (A-shares) but rather in Hong Kong-listed H-shares and other eligible securities.
Investors should be aware that FXI’s performance can be influenced by China’s regulatory environment, geopolitical tensions, and currency fluctuations. The fund is structured as a U.S. investment company, which may have implications for tax efficiency compared to other ETF structures. For fund managers and investors, FXI serves as a liquid and established vehicle to gain exposure to China’s large-cap market, though it’s essential to evaluate the fund’s holdings and the broader macroeconomic context of Chinese equities.
Additional Sources for FXI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
FXI ETF Overview
Market Cap in USD | 5,539m |
Category | China Region |
TER | 0.74% |
IPO / Inception | 2004-10-05 |
FXI ETF Ratings
Growth Rating | -4.93 |
Fundamental | - |
Dividend Rating | 16.4 |
Rel. Strength | 25.5 |
Analysts | - |
Fair Price Momentum | 32.86 USD |
Fair Price DCF | - |
FXI Dividends
Dividend Yield 12m | 1.67% |
Yield on Cost 5y | 1.54% |
Annual Growth 5y | -12.02% |
Payout Consistency | 92.5% |
FXI Growth Ratios
Growth Correlation 3m | 12.8% |
Growth Correlation 12m | 79.5% |
Growth Correlation 5y | -66.1% |
CAGR 5y | -0.42% |
CAGR/Max DD 5y | -0.01 |
Sharpe Ratio 12m | 0.12 |
Alpha | 29.25 |
Beta | 0.747 |
Volatility | 36.15% |
Current Volume | 33284.3k |
Average Volume 20d | 51218.2k |
As of April 25, 2025, the stock is trading at USD 34.11 with a total of 33,284,278 shares traded.
Over the past week, the price has changed by +5.28%, over one month by -6.98%, over three months by +8.91% and over the past year by +37.44%.
Neither. Based on ValueRay Analyses, iShares China Large-Cap is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -4.93 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of FXI as of April 2025 is 32.86. This means that FXI is currently overvalued and has a potential downside of -3.66%.
iShares China Large-Cap has no consensus analysts rating.
According to ValueRays Forecast Model, FXI iShares China Large-Cap will be worth about 36.5 in April 2026. The stock is currently trading at 34.11. This means that the stock has a potential upside of +7.12%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 36.5 | 7.1% |